Barry A. Boilson

This study is testing if a drug called daratumumab can lower high levels of harmful antibodies in people waiting for a heart transplant. High antibodies make it very hard to find a compatible donor heart. The goal is to see if this treatment can 'desensitize' patients, making mor…